BioStem Technologies, Inc. (BSEM)
3.88
+0.08
(+2.11%)
USD |
NASDAQ |
Sep 24, 16:00
3.84
-0.04
(-1.03%)
After-Hours: 19:59
BioStem Technologies Gross Profit (Annual) : 44.22M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 44.22M |
| December 31, 2024 | 55.70M |
| December 31, 2023 | 15.20M |
| December 31, 2022 | 5.75M |
| December 31, 2021 | 2.403M |
| December 31, 2020 | 1.010M |
| December 31, 2019 | 0.9767M |
| December 31, 2018 | 0.2121M |
| December 31, 2017 | -0.0223M |
| Date | Value |
|---|---|
| December 31, 2016 | 0.2131M |
| December 31, 2015 | 0.0846M |
| December 31, 2014 | 0.00 |
| December 31, 2013 | -0.014M |
| December 31, 2012 | -0.2217M |
| December 31, 2011 | 0.4834M |
| December 31, 2010 | 0.6082M |
| December 31, 2009 | 0.0887M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Filana Therapeutics, Inc. | -0.936M |
| CorMedix, Inc. | 275.75M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | -0.0253M |
| Cardiac Biotech Solutions, Inc. | 0.00 |